PMID: 15232326Jul 3, 2004Paper

A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features

Journal of Clinical Psychopharmacology
Anthony J RothschildGary D Tollefson

Abstract

The purpose of this study was to compare the efficacy and safety of olanzapine (OLZ) monotherapy and an olanzapine/fluoxetine combination (OFC) with placebo (PLA) for unipolar major depression with psychotic features. Under a single protocol, two 8-week, double-blind trials were conducted at 27 sites. Patients (n = 124 trial 1, n = 125 trial 2) were randomized to 1 of 3 treatment groups: OLZ (5 to 20 mg/d), PLA, or OFC (olanzapine 5 to 20 mg/d + fluoxetine 20 to 80 mg/d). The primary outcome measure was the 24-item Hamilton Depression Rating Scale total score. For trial 1, endpoint improvement for the OLZ group (-14.9) was not significantly different from the PLA or OFC groups. The OFC group had significantly greater endpoint improvement (-20.9) than the PLA group (-10.4, P = 0.001); this significant difference was present within 7 days of therapy and maintained at every subsequent visit. The OFC group also had significantly higher response rate (63.6%) than the PLA (28.0%, P = 0.004) or OLZ (34.9%, P = 0.027) groups. For trial 2, there were no significant differences among treatment groups on the 24-item Hamilton Depression Rating Scale total scores or response rates. The combination exhibited a comparable safety profile with ...Continue Reading

References

Jul 1, 1975·The American Journal of Psychiatry·A H GlassmanM Shostak
Sep 1, 1990·The American Journal of Psychiatry·R F Anton, E A Burch
Jan 1, 1988·Comprehensive Psychiatry·T A AronsonE Khan
Sep 1, 1986·Journal of Affective Disorders·B S Meyers, R Greenberg
Apr 1, 1985·The American Journal of Psychiatry·D G SpikerP H Soloff
Sep 1, 1983·The American Journal of Psychiatry·S P RooseJ Vital-Herne
Apr 1, 1981·Archives of General Psychiatry·A H Glassman, S P Roose
Mar 1, 1996·The American Journal of Psychiatry·F GattiE Smeraldi
Feb 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·F P BymasterD T Wong
Jun 1, 1996·The Psychiatric Clinics of North America·A J Rothschild
Jul 1, 1997·International Clinical Psychopharmacology·R ZanardiJ Perez
Nov 14, 1997·The American Journal of Psychiatry·C DebattistaA F Schatzberg
Mar 20, 1999·The Journal of Clinical Psychiatry·A J RothschildA Syed
Apr 22, 1999·The British Journal of Psychiatry : the Journal of Mental Science·P V TranC M Beasley
Jun 9, 1999·The American Journal of Psychiatry·A J Rothschild, K A Phillips
Jul 17, 1999·Statistics in Medicine·P S Albert
Jan 5, 2000·The British Journal of Psychiatry : the Journal of Mental Science·N Purandare, S Plunkett
Jan 5, 2000·The British Journal of Psychiatry : the Journal of Mental Science·G S Malhi, S A Checkley
Aug 16, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·W ZhangF P Bymaster
Jan 4, 2001·The American Journal of Psychiatry·R C SheltonH Y Meltzer
Apr 10, 2002·JAMA : the Journal of the American Medical Association·B Timothy WalshMadelyn Gould

❮ Previous
Next ❯

Citations

Aug 10, 2006·Psychopharmacology·Khrista BoylanBoris Birmaher
Apr 7, 2005·European Archives of Psychiatry and Clinical Neuroscience·Hans-Jürgen Möller
Jul 3, 2013·Asian Journal of Psychiatry·Massimiliano BuoliAlfredo Carlo Altamura
Oct 2, 2012·Journal of Affective Disorders·Anne Katrine K LeadholmSøren Dinesen Ostergaard
Oct 28, 2005·The New England Journal of Medicine·J John Mann
Jun 6, 2007·Schizophrenia Bulletin·Jennifer KellerMario Maj
Apr 20, 2013·Schizophrenia Bulletin·Anthony J Rothschild
Jun 24, 2008·Neuropsychiatric Disease and Treatment·Yuka SugawaraTetsuo Shimizu
Aug 2, 2008·Clinical Neuropharmacology·Chang-Chih HuangYi-Wei Yeh
Apr 15, 2008·International Clinical Psychopharmacology·Eric SmithUNKNOWN STOP-PD Collaborative Study Group
Jan 22, 2010·CNS Drugs·Richard C SheltonSara A Corya
Dec 22, 2009·The Journal of Clinical Psychiatry·Brandon A Gaudiano, Mark Zimmerman
Jan 29, 2011·The Journal of Clinical Psychiatry·George S Alexopoulos
Aug 20, 2014·The Medical Clinics of North America·L Renata Thronson, Genevieve L Pagalilauan
Apr 24, 2013·Journal of Clinical Psychopharmacology·Daniel M BlumbergerBarnett S Meyers
Jun 13, 2009·Nordic Journal of Psychiatry·Christina M DordingDavid Mischoulon
Jan 1, 2008·International Journal of Psychiatry in Clinical Practice·Mazda AdliMichael Bauer
Jan 1, 2008·International Journal of Psychiatry in Clinical Practice·Nobutaka MotohashiTeruhiko Higuchi
Oct 31, 2012·The Psychiatric Clinics of North America·William J Newman
Sep 16, 2008·European Psychiatry : the Journal of the Association of European Psychiatrists·Athanasios Koukopoulos, S Nassir Ghaemi
Oct 12, 2007·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·George S AlexopoulosCharles Reynolds
Jun 15, 2007·Comprehensive Psychiatry·Brandon A Gaudiano, Ivan W Miller
Oct 4, 2007·Journal of the American Geriatrics Society·Gene A Nakajima, Neil S Wenger
Nov 13, 2013·Bipolar Disorders·Søren Dinesen ØstergaardJimmi Nielsen
Jun 27, 2013·Acta Psychiatrica Scandinavica·S D ØstergaardUNKNOWN STOP-PD Study Group
May 29, 2015·Acta Psychiatrica Scandinavica·S D ØstergaardB S Meyers
Sep 12, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·A KonstantinidisS Kasper
May 9, 2006·The Journal of Emergency Medicine·Jason VenaTodd Paige
Jan 31, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Panayiota G Michalopoulou, Lefteris Lykouras
May 13, 2015·Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists·Rona Jeannie RobertsRif S El-Mallakh
Jun 17, 2014·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alan F Schatzberg
Oct 13, 2010·Journal of Psychiatric Research·Ragy R GirgisJeffrey A Lieberman
Dec 9, 2015·The Australian and New Zealand Journal of Psychiatry·Gin S MalhiAjeet B Singh
Aug 26, 2014·Journal of Psychopharmacology·Saeed Farooq, Surendra P Singh
Dec 15, 2010·The Cochrane Database of Systematic Reviews·Katja KomossaStefan Leucht
Aug 1, 2015·The Cochrane Database of Systematic Reviews·Jaap WijkstraWillem A Nolen
Jul 29, 2008·Harvard Review of Psychiatry·Hesham M Hamoda, David N Osser
Jan 15, 2009·Journal of Clinical Psychopharmacology·John D MatthewsMaurizio Fava

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here